CVRdatabase
Menu

Incyte Biosciences Denmark ApS

Private limited companyCVR 35818790Frederiksberg CActive

Incyte Biosciences Denmark ApS is a private limited company, based in Frederiksberg C, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2014. Equity grew to DKK 2.3m in 2025. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 6.7m−5% vs. 2024
Net profitDKK 361k−2.1% vs. 2024
EquityDKK 2.3m+18.4% vs. 2024
Employees4latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 5% (2024 → 2025), to DKK 6.7m.
  • Net profit fell 2% (2024 → 2025), to DKK 361k.
  • Equity rose 18% (2024 → 2025), to DKK 2.3m.

Management and owners, last 24 months

  • New in management: Ebba Cecilia Bröms (board member, 25/02/2026), Ebba Cecilia Bröms (director, 25/02/2026) and Erik Garardus Johannes Bokmans (board member, 27/02/2025) (+1).
  • Stepped down: Erik Thomas Fromm (board member, 27/02/2025), Erik Thomas Fromm (director, 27/02/2025) and Erik Garardus Johannes Bokmans (board member, 25/02/2026) (+1).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 500kDKK 1mDKK 1.5mDKK 2mDKK 2.5m202020212022202320242025
EquityNet profit
Financial figures for Incyte Biosciences Denmark ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit5,3975,2885,5576,2837,0466,697−5%
Operating profit (EBIT)214364371485473461−2.4%
Profit before tax199346355486465463−0.3%
Net profit150269278375369361−2.1%
Total assets3,3713,4426,9914,6033,7404,010+7.2%
Equity6779461,2241,5981,9672,328+18.4%
Liabilities2,6942,4965,7673,0051,7721,681−5.1%
Cash and cash equivalents739376531,583540752+39.2%
Average number of employees3444440%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 2mDKK 4mDKK 6mDKK 8mDKK 10mDKK 12m202020212022202320242025
Gross profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Incyte Biosciences Denmark ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202510/07/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202426/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202328/05/2024The companyPDFXBRL
202201/01/2022 – 31/12/202217/05/2023The companyPDFXBRL
202101/01/2021 – 31/12/202106/04/2022The companyPDFXBRL
202001/01/2020 – 31/12/202007/05/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0123408/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 6.7mNo. 135 of 232
Better than 42% of the companies in the industry
EquityDKK 2.3mNo. 167 of 232
Better than 28% of the companies in the industry
Number of employees4No. 146 of 232
Better than 37% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 9,168of 69,742
Better than 87%
No. 22,407of 69,964
Better than 68%
Same industry and fewer than 20 employees150 companies in the comparison
No. 55of 150
Better than 64%
No. 86of 150
Better than 43%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 6,580of 33,588
Better than 80%
No. 9,905of 33,687
Better than 71%
All companies of type ApS66,508 companies in the comparison
No. 9,981of 66,379
Better than 85%
No. 18,705of 66,505
Better than 72%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. Incyte Biosciences Denmark ApSDKK 6.7m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. Incyte Biosciences Denmark ApSDKK 361k
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. Incyte Biosciences Denmark ApSDKK 2.3m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. Incyte Biosciences Denmark ApS4
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Incyte Biosciences International Sàrl100%
Incyte Biosciences Denmark ApS

Management

3 active registrations

Executive management

Executive management at Incyte Biosciences Denmark ApS
NameRoleAppointed
Ebba Cecilia BrömsDirector25/02/2026

Board of directors

Board of directors at Incyte Biosciences Denmark ApS
NameRoleAppointed
Lee Jason HeesonChair of the board01/10/2024
Ebba Cecilia BrömsBoard member25/02/2026
Auditor
Grant Thornton, Godkendt Revisionspartnerselskab
Founders
Kimara & co advokatanpartsselskab
Former management (5)
Former management at Incyte Biosciences Denmark ApS
NameRoleAppointedResigned
Erik Thomas FrommBoard member01/04/201427/02/2025
Erik Thomas FrommDirector01/04/201427/02/2025
Jonathan Elliot DickinsonChair of the board01/04/201430/09/2024
Erik Garardus Johannes BokmansBoard member27/02/202525/02/2026
Erik Garardus Johannes BokmansDirector27/02/202525/02/2026

Signing rule: Selskabet tegnes af et bestyrelsesmedlem alene eller af en direktør alene.

Address and production units

1 active production units

Suomisvej 4
1927 Frederiksberg C

Frederiksberg Municipality · Postcode 1927

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
Incyte Biosciences Denmark ApSSuomisvej 4, 1927 Frederiksberg C41019269449

Purpose

Selskabets formål er at udbrede medicinsk og farmaceutisk viden og aktivitet, handel med medicinalvareprodukter samt enhver virksomhed som er beslægtet hermed.

The purpose is quoted from the register in Danish.

Changes year by year

26 registered events
20265 changesaccounts 1 · management 4
  • Annual report for 2025 published
  • Ebba Cecilia Bröms appointed board member
  • Ebba Cecilia Bröms appointed director
  • Erik Garardus Johannes Bokmans stepped down as director
  • Erik Garardus Johannes Bokmans stepped down as board member
20255 changesaccounts 1 · management 4
  • Annual report for 2024 published
  • Erik Garardus Johannes Bokmans appointed director
  • Erik Garardus Johannes Bokmans appointed board member
  • Erik Thomas Fromm stepped down as board member
  • Erik Thomas Fromm stepped down as director
20243 changesmanagement 2 · accounts 1
  • Lee Jason Heeson appointed chair of the board
  • Jonathan Elliot Dickinson stepped down as chair of the board
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20181 changeaddress 1
  • Moved to Suomisvej 4, 1927 Frederiksberg C
20172 changesownership 2
  • Incyte Biosciences International Sàrl registered as owner (100%)
  • Incyte Biosciences Luxembourg Sàrl is no longer registered as owner
20161 changename 1
  • Name changed from ARIAD PHARMACEUTICALS (DENMARK) ApS to Incyte Biosciences Denmark ApS
20151 changeownership 1
  • Incyte Biosciences Luxembourg Sàrl registered as owner (100%)
20145 changesaddress 1 · founded 1 · management 3
  • Moved to Arne Jacobsens Allé 7, 5, 2300 København S
  • Registered as ARIAD PHARMACEUTICALS (DENMARK) ApS
  • Erik Thomas Fromm appointed board member
  • Jonathan Elliot Dickinson appointed chair of the board
  • Erik Thomas Fromm appointed director

Related companies

Same industry in Frederiksberg

See all →

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction